{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:52:45Z","timestamp":1791298365744,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Friends of Integrative Oncology Care"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"DOI":"10.1038\/s41416-026-03627-3","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:42Z","timestamp":1791296982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in incidence and prevalence of patients living long-term with de novo metastatic incurable cancer: a retrospective cohort study"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7345-8906","authenticated-orcid":false,"given":"Ruben","family":"Bouma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8864-4887","authenticated-orcid":false,"given":"Olaf P.","family":"Geerse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3000-2520","authenticated-orcid":false,"given":"Natasja J. H.","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-3806","authenticated-orcid":false,"given":"Heidi P.","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7142-7605","authenticated-orcid":false,"given":"Lia","family":"van Zuylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1678-7816","authenticated-orcid":false,"given":"Anna K. L.","family":"Reyners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9679-2177","authenticated-orcid":false,"given":"Kristel","family":"van Asselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2418-7039","authenticated-orcid":false,"given":"Maatje D. A.","family":"van Gastel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8054-7337","authenticated-orcid":false,"given":"Daan","family":"Brandenbarg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8491-1407","authenticated-orcid":false,"given":"Mariken E.","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"3627_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin Wiley. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin Wiley"},{"key":"3627_CR2","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1093\/jnci\/djac158","volume":"114","author":"L Gallicchio","year":"2022","unstructured":"Gallicchio L, Devasia TP, Tonorezos E, Mollica MA, Mariotto A. Estimation of the Number of Individuals Living with Metastatic Cancer in the United States. J Natl Cancer Inst Oxf Univ Press. 2022;114:1476\u201383. https:\/\/doi.org\/10.1093\/jnci\/djac158.","journal-title":"J Natl Cancer Inst Oxf Univ Press"},{"key":"3627_CR3","doi-asserted-by":"publisher","unstructured":"White R, Stanley F, Than J, MacNair A, Pethick J, Fallica G, et al. Treatable but not curable cancer in England: A retrospective cohort study using cancer registry data and linked data sets. BMJ Open. BMJ Publishing Group; 2021;11. https:\/\/doi.org\/10.1136\/bmjopen-2020-040808.","DOI":"10.1136\/bmjopen-2020-040808"},{"key":"3627_CR4","unstructured":"IKNL. Uitgezaaide kanker in beeld [Internet]. 2020 [cited 2025 Apr 8]. https:\/\/iknl.nl\/nieuws\/2020\/uitgezaaide-kanker-in-beeld. Accessed 8 Apr 2025"},{"key":"3627_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s43856-023-00304-x","volume":"3","author":"NL Hudock","year":"2023","unstructured":"Hudock NL, Mani K, Khunsriraksakul C, Walter V, Nekhlyudov L, Wang M, et al. Future trends in incidence and long-term survival of metastatic cancer in the United States. Commun Med Springe Nat. 2023;3:76. https:\/\/doi.org\/10.1038\/s43856-023-00304-x.","journal-title":"Commun Med Springe Nat"},{"key":"3627_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/COC.0000000000000866","volume":"44","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, Stoltzfus KC, Jones BM, Gusani NJ, Walter V, Wang M, et al. Trends in diagnosis and treatment of metastatic cancer in the United States. Am J Clin Oncol: Cancer Clin Trials Lippincott Williams Wilkins. 2021;44:572\u20139. https:\/\/doi.org\/10.1097\/COC.0000000000000866.","journal-title":"Am J Clin Oncol: Cancer Clin Trials Lippincott Williams Wilkins"},{"key":"3627_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnci\/djad020","volume":"115","author":"M Luyendijk","year":"2023","unstructured":"Luyendijk M, Visser O, Blommestein HM, de Hingh IHJT, Hoebers FJP, Jager A, et al. Changes in survival in de novo metastatic cancer in an era of new medicines. J Natl Cancer Inst NLM (Medlin). 2023;115:628\u201335. https:\/\/doi.org\/10.1093\/jnci\/djad020.","journal-title":"J Natl Cancer Inst NLM (Medlin)"},{"key":"3627_CR8","doi-asserted-by":"publisher","unstructured":"Zeineddine FA, Zeineddine MA, Yousef A, Gu Y, Chowdhury S, Dasari A, et al. Survival improvement for patients with metastatic colorectal cancer over twenty years. NPJ Precis Oncol. Nature Research; 2023;7. https:\/\/doi.org\/10.1038\/s41698-023-00353-4.","DOI":"10.1038\/s41698-023-00353-4"},{"key":"3627_CR9","doi-asserted-by":"publisher","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med. Sci. (Basel). NLM (Medline); 2021. p.63. https:\/\/doi.org\/10.3390\/medsci9040063.","DOI":"10.3390\/medsci9040063"},{"key":"3627_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/02692163251400114","volume":"40","author":"R Bouma","year":"2026","unstructured":"Bouma R, Stegmann ME, Raijmakers NJH, van Zuylen L, Reyners AKL, van Asselt K, et al. Defining patients living long-term with incurable cancer: a modified hybrid Delphi study. Palliat Med [Internet] SAGE Publ Ltd. 2026;40:217\u201327. https:\/\/doi.org\/10.1177\/02692163251400114;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Palliat Med [Internet] SAGE Publ Ltd"},{"key":"3627_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.3390\/cancers13112555","volume":"13","author":"ME Stegmann","year":"2021","unstructured":"Stegmann ME, Geerse OP, van Zuylen L, Nekhlyudov L, Brandenbarg D. Improving care for patients living with prolonged incurable cancer. Cancers (Basel) MDPI. 2021;13:2555. https:\/\/doi.org\/10.3390\/cancers13112555.","journal-title":"Cancers (Basel) MDPI"},{"key":"3627_CR12","doi-asserted-by":"publisher","unstructured":"Kolsteren EEM, Deuning-Smit E, Chu AK, van der Hoeven YCW, Prins JB, van der Graaf WTA, et al. Psychosocial aspects of living long term with advanced cancer and ongoing systemic treatment: a scoping review. Cancers (Basel). MDPI; 2022. p.3889. https:\/\/doi.org\/10.3390\/cancers14163889","DOI":"10.3390\/cancers14163889"},{"key":"3627_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1200\/op.20.00183","volume":"16","author":"L Spoozak","year":"2020","unstructured":"Spoozak L, Wulff-Burchfield E, Brooks JV. Rallying cry from the place in between. JCO Oncol Pract Am Soc Clin Oncol (ASCO). 2020;16:451\u20132. https:\/\/doi.org\/10.1200\/op.20.00183.","journal-title":"JCO Oncol Pract Am Soc Clin Oncol (ASCO)"},{"key":"3627_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jnci\/djab223","volume":"114","author":"MA Mollica","year":"2022","unstructured":"Mollica MA, Smith AW, Tonorezos E, Castro K, Filipski KK, Guida J, et al. Survivorship for individuals living with advanced and metastatic cancers: National Cancer Institute Meeting Report. J Natl Cancer Inst Oxf Univ Press. 2022;114:489\u201395. https:\/\/doi.org\/10.1093\/jnci\/djab223.","journal-title":"J Natl Cancer Inst Oxf Univ Press"},{"key":"3627_CR15","unstructured":"Netherlands Cancer Registry (NCR) [Internet]. [cited 2025 May 19]. https:\/\/iknl.nl\/en\/ncr. Accessed 19 May 2025"},{"key":"3627_CR16","unstructured":"International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3) [Internet]. [cited 2025 May 19]. https:\/\/www.who.int\/standards\/classifications\/other-classifications\/international-classification-of-diseases-for-oncology. Accessed 19 May 2025"},{"key":"3627_CR17","unstructured":"TNM Classification of Malignant Tumours, 8th edition | UICC [Internet]. [cited 2025 May 19]. https:\/\/www.uicc.org\/resources\/tnm-classification-malignant-tumours-8th-edition. Accessed 19 May 2025"},{"key":"3627_CR18","unstructured":"NKR Cijfers | Incidentie [Internet]. [cited 2025 Jul 1]. https:\/\/nkr-cijfers.iknl.nl\/viewer\/incidentie-per-jaar?language=nl_NL&viewerId=3b55d752-ce1a-4809-89d9-8421febdb1f4. Accessed 1 Jul 2025"},{"key":"3627_CR19","unstructured":"Feiten en cijfers huisartsenzorg - LHV [Internet]. [cited 2025 Jun 25]. https:\/\/www.lhv.nl\/opkomen-voor-belangen\/feiten-en-cijfers-huisartsenzorg\/. Accessed 25 Jun 2025"},{"key":"3627_CR20","unstructured":"Statistics Netherlands (2015) Average disposable household income per postcode area. [Internet]. [cited 2025 Aug 19]. https:\/\/www.cbs.nl\/en-gb\/custom\/2015\/38\/average-disposable-household-income-per-postcode-area-2012. Accessed 19 Aug 2025"},{"key":"3627_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"3627_CR22","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJMP1901103\/SUPPL_FILE\/NEJMP1901103_DISCLOSURES.PDF","volume":"380","author":"T Langbaum","year":"2019","unstructured":"Langbaum T, Smith TJ. Time to Study Metastatic-Cancer Survivorship. N Engl J Med [Internet] Mass Med Soc. 2019;380:1300\u20132. https:\/\/doi.org\/10.1056\/NEJMP1901103\/SUPPL_FILE\/NEJMP1901103_DISCLOSURES.PDF. [cited 2025 Apr 8].","journal-title":"N Engl J Med [Internet] Mass Med Soc"},{"key":"3627_CR23","doi-asserted-by":"publisher","unstructured":"Geerse OP, Lakin JR, Berendsen AJ, Alfano CM, Nekhlyudov L. Cancer survivorship and palliative care: Shared progress, challenges, and opportunities. Cancer. John Wiley and Sons Inc.; 2018. p.4435\u201341. https:\/\/doi.org\/10.1002\/cncr.31723","DOI":"10.1002\/cncr.31723"},{"key":"3627_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMOA1713137","volume":"378","author":"J-C Soria","year":"2018","unstructured":"Soria J-C, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, et al. Osimertinib in untreated EGFR -mutated advanced non\u2013small-cell lung cancer. N Engl J Med [Internet] Mass Med Soc. 2018;378:113\u201325. https:\/\/doi.org\/10.1056\/NEJMOA1713137.","journal-title":"N Engl J Med [Internet] Mass Med Soc"},{"key":"3627_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMOA1913662","volume":"382","author":"SS Ramalingam","year":"2020","unstructured":"Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, et al. Overall survival with osimertinib in untreated, EGFR -mutated advanced NSCLC. N Engl J Med [Internet] Mass Med Soc. 2020;382:41\u201350. https:\/\/doi.org\/10.1056\/NEJMOA1913662. [cited 2025 May 14].","journal-title":"N Engl J Med [Internet] Mass Med Soc"},{"key":"3627_CR26","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1158\/2767-9764.CRC-23-0340","volume":"3","author":"K Simmons","year":"2023","unstructured":"Simmons K, Thomas JV, Ludford K, Willis JA, Higbie VS, Raghav KPS, et al. Sustained disease control in immune checkpoint blockade responders with microsatellite instability-high colorectal cancer after treatment termination. Cancer Res Commun [Internet] Am Assoc Cancer Res Inc. 2023;3:2510. https:\/\/doi.org\/10.1158\/2767-9764.CRC-23-0340.","journal-title":"Cancer Res Commun [Internet] Am Assoc Cancer Res Inc"},{"key":"3627_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/CELLS13030245","volume":"13","author":"PW Underwood","year":"2024","unstructured":"Underwood PW, Ruff SM, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. 2024;13:245. https:\/\/doi.org\/10.3390\/CELLS13030245. [Internet]. Multidisciplinary Digital Publishing Institute; 2024 [cited 2025 Apr 8].","journal-title":"Cells"},{"key":"3627_CR28","doi-asserted-by":"publisher","first-page":"e076625","DOI":"10.1136\/bmj-2023-076625","volume":"384","author":"ECT Geijteman","year":"2024","unstructured":"Geijteman ECT, Kuip EJM, Oskam J, Lees D, Bruera E. Illness trajectories of incurable solid cancers. BMJ BMJ Publ Group. 2024;384:e076625. https:\/\/doi.org\/10.1136\/bmj-2023-076625.","journal-title":"BMJ BMJ Publ Group"},{"key":"3627_CR29","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1007\/s00520-019-05285-z","volume":"28","author":"ME Stegmann","year":"2020","unstructured":"Stegmann ME, Geerse OP, Tange D, Richel C, Brom L, Engelen V, et al. Experiences and needs of patients with incurable cancer regarding advance care planning: results from a national cross-sectional survey. Supportive Care Cancer Springe. 2020;28:4211\u20137. https:\/\/doi.org\/10.1007\/s00520-019-05285-z.","journal-title":"Supportive Care Cancer Springe"},{"key":"3627_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","volume":"33","author":"I Vaz-Luis","year":"2022","unstructured":"Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol [Internet] Elsevier Ltd. 2022;33:1119\u201333. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.1941.","journal-title":"Ann Oncol [Internet] Elsevier Ltd"},{"key":"3627_CR31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s11764-022-01306-9","volume":"18","author":"LC Zwanenburg","year":"2022","unstructured":"Zwanenburg LC, Suijkerbuijk KPM, van Dongen SI, Koldenhof JJ, van Roozendaal AS, van der Lee ML, et al. Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy. J Cancer Survivorship Springe. 2022;18:750\u201360. https:\/\/doi.org\/10.1007\/s11764-022-01306-9.","journal-title":"J Cancer Survivorship Springe"},{"key":"3627_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/S11764-021-01024-8","volume":"15","author":"J Lai-Kwon","year":"2021","unstructured":"Lai-Kwon J, Heynemann S, Flore J, Dhillon H, Duffy M, Burke J, et al. Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy. J Cancer Survivorship. 2021;15:392\u20137. https:\/\/doi.org\/10.1007\/S11764-021-01024-8.","journal-title":"J Cancer Survivorship"},{"key":"3627_CR33","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/S00520-018-4443-3","volume":"27","author":"D Levy","year":"2018","unstructured":"Levy D, Dhillon HM, Lomax A, Marthick M, McNeil C, Kao S, et al. Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy. Supportive Care Cancer. 2018;27:1845\u201352. https:\/\/doi.org\/10.1007\/S00520-018-4443-3.","journal-title":"Supportive Care Cancer"},{"key":"3627_CR34","doi-asserted-by":"publisher","unstructured":"Tometich DB, Hyland KA, Soliman H, Jim HSL, Oswald L. Living with metastatic cancer: A roadmap for future research. Cancers (Basel). MDPI AG; 2020. p.1\u201324. https:\/\/doi.org\/10.3390\/cancers12123684.","DOI":"10.3390\/cancers12123684"},{"key":"3627_CR35","doi-asserted-by":"publisher","unstructured":"Hart NH, Nekhlyudov L, Smith TJ, Yee J, Fitch MI, Crawford GB, et al. Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations. Supportive Care in Cancer. Springer Science and Business Media Deutschland GmbH; 2024;32. https:\/\/doi.org\/10.1007\/s00520-024-08465-8.","DOI":"10.1007\/s00520-024-08465-8"},{"key":"3627_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101786","volume":"67","author":"H You","year":"2026","unstructured":"You H, Creighton N, Walton RJ, Lord SJ, Smith AL, Kiely BE, et al. Estimating the number of people living with metastatic breast cancer: a population-based retrospective cohort study using linked health data. Lancet Reg Health West Pac [Internet] Elsevier Ltd. 2026;67:101786. https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101786.","journal-title":"Lancet Reg Health West Pac [Internet] Elsevier Ltd"},{"key":"3627_CR37","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/jcm10102131","volume":"10","author":"M Molla","year":"2021","unstructured":"Molla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, et al. Clinical medicine limited liver or lung colorectal cancer metastases. Systemic treatment, surgery, ablation or SBRT. J Clin Med. 2021;10:2131. https:\/\/doi.org\/10.3390\/jcm10102131.","journal-title":"J Clin Med"},{"key":"3627_CR38","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.3390\/CANCERS14205000","volume":"14","author":"C Ladbury","year":"2022","unstructured":"Ladbury C, Hao C, Ruel C, Liu J, Glaser S, Amini A, et al. Oligometastatic breast cancer patients treated with high-dose chemotherapy and targeted radiation: long-term follow-up of a phase II trial. Cancers (Basel) [Internet] MDPI. 2022;14:5000. https:\/\/doi.org\/10.3390\/CANCERS14205000.","journal-title":"Cancers (Basel) [Internet] MDPI"},{"key":"3627_CR39","unstructured":"Fewer cancer diagnoses in 2020 due to COVID-19 crisis in the Netherlands: first decrease in thirty years [Internet]. [cited 2026 Jun 23]. https:\/\/iknl.nl\/en\/news\/fewer-cancer-diagnoses-in-2020-due-to-covid-19-(1). Accessed 23 Jun 2026"},{"key":"3627_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/S41416-018-0090-1","volume":"119","author":"Derks","year":"2018","unstructured":"Derks, Bastiaannet MGM, Kiderlen E, Hilling DE M, Boelens PG, Walsh PM, et al. Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group. Br J Cancer [Internet] Nat Publ Group. 2018;119:121. https:\/\/doi.org\/10.1038\/S41416-018-0090-1.","journal-title":"Br J Cancer [Internet] Nat Publ Group"},{"key":"3627_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/J.BREAST.2026.104778","volume":"87","author":"H Fink","year":"2026","unstructured":"Fink H, Soerjomataram I, Bardot A, Brennan A, Woods RR, Gonsalves L, et al. International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study. Breast: Off J Eur Soc Mastology [Internet] Churchill Livingstone. 2026;87:104778. https:\/\/doi.org\/10.1016\/J.BREAST.2026.104778.","journal-title":"Breast: Off J Eur Soc Mastology [Internet] Churchill Livingstone"},{"key":"3627_CR42","doi-asserted-by":"publisher","unstructured":"Kolsteren EEM, Deuning-Smit E, Prins JB, van der Graaf WTA, Kwakkenbos L, Custers JAE. Perspectives of patients, partners, primary and hospital-based health care professionals on living with advanced cancer and systemic treatment. J Cancer Surviv. Springer; 2024; https:\/\/doi.org\/10.1007\/s11764-024-01698-w.","DOI":"10.1007\/s11764-024-01698-w"},{"key":"3627_CR43","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1200\/JCO.22.02212;PAGEGROUP:STRING:PUBLICATION","volume":"41","author":"J Lai-Kwon","year":"2023","unstructured":"Lai-Kwon J, Heynemann S, Hart NH, Chan RJ, Smith TJ, Nekhlyudov L, et al. Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era. J Clin Oncol [Internet] Lippincott Williams Wilkins. 2023;41:3304\u201310. https:\/\/doi.org\/10.1200\/JCO.22.02212;PAGEGROUP:STRING:PUBLICATION.","journal-title":"J Clin Oncol [Internet] Lippincott Williams Wilkins"},{"key":"3627_CR44","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/J.ANNONC.2022.07.1941","volume":"33","author":"I Vaz-Luis","year":"2022","unstructured":"Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol [Internet] Elsevier. 2022;33:1119\u201333. https:\/\/doi.org\/10.1016\/J.ANNONC.2022.07.1941. [cited 2026 Jun 30].","journal-title":"Ann Oncol [Internet] Elsevier"},{"key":"3627_CR45","unstructured":"Guidelines on Survivorship Care - ASCO [Internet]. [cited 2026 Jun 30]. https:\/\/www.asco.org\/news-initiatives\/current-initiatives\/cancer-care-initiatives\/prevention-survivorship\/survivorship-compendium\/guidelines. Accessed 30 Jun 2026."},{"key":"3627_CR46","doi-asserted-by":"publisher","unstructured":"Bouritius EM, Bergman TD, Pasman HRW, Kager CCM, Onwuteaka-Philipsen BD. Palliative care in general practice for patients with cancer, organ failure and dementia or old-age: a cross-sectional study among general practitioners. BMC primary care [Internet]. BMC Prim Care; 2026 [cited 2026 Jun 22];27. https:\/\/doi.org\/10.1186\/S12875-026-03280-Y.","DOI":"10.1186\/S12875-026-03280-Y"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03627-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03627-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03627-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:46Z","timestamp":1791296986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03627-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":46,"alternative-id":["3627"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03627-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was registered in the PaNaMa research management system of the University Medical Center Groningen (PaNaMa ID 18065). Anonymized data were obtained from the Netherlands Cancer Registry (NCR), maintained by the Netherlands Comprehensive Cancer Organisation (IKNL), and no directly identifiable patient information was accessed. According to applicable Dutch regulations for registry-based research using anonymized data, individual informed consent was not required. Use of NCR data for this study was approved by the Privacy Review Board of the NCR\/IKNL.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"As this study used anonymized data from a national database, consent for publication was not required.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}